Ibogaine and Its Controversial Role in Therapy

This chapter investigates the media coverage of DePay's use of Ibogaine, a psychedelic drug often associated with addiction treatment. It features expert insights on the therapeutic effects of Ibogaine, raising questions about its implications in the context of violent behavior and the need for regulatory oversight. The discussion also highlights the ongoing challenges in drug treatment policies and the potential for psychedelic therapies to reshape addiction recovery.